Increasing adoption in pharmaceuticals sector fueling growth
of the hyperspectral imaging market, especially in emerging economies
The global Hyperspectral
Imaging Systems Market globe is expected to witness double digit growth in
the near future. In healthcare sector, these systems are used to perform
various procedures in the pharmaceuticals industry. These include systems used
to perform quality control tests that help detect foreign material present in
drugs, and also mixed chemicals in counterfeit drugs. Also, hyperspectral
imaging systems help in identification of targeted tumor tissue, a blood
vessel, lymph nodes, a nerve bundle by covering the surface area of target and
providing the image, in which that pixels of the image contains information
regarding various light wavelength bands. Also, hyperspectral imaging finds
extensive application in cancer treatment, as these systems provide real-time
data and help in understanding the changes of tissue, which occur in the early
stages of development of disease, also it helps to differentiate healthy cells
from cancerous cells.
North America holds the largest share in the global hyperspectral
imaging systems market, followed by Europe. This is mainly attributed to high
healthcare spending, robust healthcare infrastructure, and inclination towards
adoption of novel technologies. Also, the market in APAC region is projected to
witness high growth rate over the next few years, due to increasing economic
growth and developing healthcare sector.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/240
Hyperspectral imaging (imaging
spectroscopy) systems are the result of extensive research and activity
efforts. These systems have various applications in sectors such as healthcare,
research and development, food industry, defense sector and others such as
remote sensing, calorimetry and night vision. Hyperspectral imaging differs
from multispectral imaging based on quality of image and provides greater
sensitivity than conventional or multispectral imaging. For instance,
multispectral imaging provides 2 to 20 images per dataset, while hyperspectral
imaging provides over 20 images per dataset. Also, multispectral imaging gives
4 to 20 data points per pixel, while hyperspectral imaging provides full
spectrum per pixel.
Increasing deployment of
hyperspectral imaging in healthcare sector creates a highly conducive
environment for growth of the hyperspectral imaging market in the near future.
Hyperspectral imaging finds wide application in medical imaging, ophthalmology,
and is also used in the procedures of gastrointestinal tract, in vascular
systems and in tissue diagnosis. It is also an integral part of wound analysis,
cell biology, and fluorescence microscopy. Wide application of the technology
is mainly attributed to its high accuracy and clarity.
Growth factors and restraints of
the hyperspectral imaging market
The innovative products with
advanced technology, high patient and operator safety, superior accuracy and
consistency are the leading factors driving growth of the hyperspectral imaging
market. The major challenge in this market is high cost of this systems, lack
of awareness about the applications of these systems, dearth of skilled operators,
high investment costs and implementation of healthcare regulatory policies that
delay approval for this systems in some regions.
Some are the key companies
providing innovative products in this area are Headwall Photonics, HyperMed
Imaging, Inc, Spectral Imaging Ltd., imec, Norsk Elektro Optikk AS (NEO),
SpekLED GmbH and Resonon.
Buy-Now this research
report: https://www.coherentmarketinsights.com/ongoing-insight/hyperspectral-imaging-market-240
Key Developments
Continuous technological
innovations and product launches by key players is driving growth of the
hyperspectral imaging market. For instance, in June 2018, Headwall Photonics
Inc. introduced sensor payloads consisting of hyperspectral sensors and lidar
instruments for the unmanned aerial vehicle (UAV) platform.
Moreover, key players are
adopting strategies such as facility expansions in order to expand their
product output and strengthen their position in the market. In February 2017,
Headwall Photonics set up a new facility in Boston, U.S. for its advanced
imaging sensor products. According to the company, this expansion will help
them achieve growth in three core areas: medical and biotechnology, remote
sensing, and machine vision.
Increasing number of product
approvals and distribution grants are facilitating demand for hyperspectral
imaging systems. In April 2018, HyperMed Imaging, Inc. received the CE Mark
approval for the distribution of its HyperView medical imaging system in
Europe. The HyperView System is a battery-operated, handheld, portable, and
non-invasive diagnostic imaging device used for assessing tissue oxygenation.
Market players are also focused
on strategic collaborations and partnerships to expand their product portfolio
and market share. In July 2018, SANUWAVE Health, Inc. announced a partnership
with HyperMed. The collaboration will include SNUWAVE utilizing HyperMed’s
Hyperview spectral imaging device to measure oxyhemoglobin level,
deoxyhemoglobin level, and oxygen saturation in superficial tissue.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/240
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment